2068
J . Org. Chem. 1998, 63, 2068-2069
Sch em e 1
Absolu te Con figu r a tion a n d Tota l Syn th esis
of (+)-Ep ola cta en e, a Neu r itogen ic Agen t
fr om P en icilliu m sp . BM 1689-P Active in
Hu m a n Neu r obla stom a Cells†
Shinji Marumoto, Hiroshi Kogen,* and Shunji Naruto*
Exploratory Chemistry Research Laboratories, Sankyo Co.,
Ltd. 2-58, Hiromachi 1-chome,
Shinagawa-ku Tokyo, 140-8710 J apan
Received J anuary 20, 1998
Neurotrophic factors including nerve growth factor (NGF)1
stimulate the proliferation and differentiation of neuroblasts
during their development and trigger adaptive plasticity
responses in the mature nervous system. The ability of
neurotrophic factors to control developmental neuronal
survival and adult nervous system plasticity suggests the
use of these molecules to treat neurodegeneration associated
with human diseases.2
Sch em e 2a
Epolactaene (1) was isolated as a diastereomeric mixture
at the C-15 position (ca. 5:1 ratio) from the culture broth of
Penicillium sp. BM 1689-P in 1995 by Osada et al.3 The
compound shows potent neurite outgrowth activity in the
human neuroblastoma cell line SH-SY5Y.4 Therefore, this
natural product is noteworthy in the context of new drug
development for various neurodegenerative diseases such as
dementia.5
The gross structure of 1 was deduced by Osada using
extensive NMR studies including 1H-1H COSY and HMBC.
However, the initial structural assignment did not specify
the absolute stereochemistry of the epoxy moiety, although
it did establish the (E,E,E) geometry of the conjugated triene
and the (E) configuration of the R,â-unsaturated ketone. We
describe here the asymmetric total synthesis of (+)-epolac-
taene via a convergent approach that utilizes epoxyamide
2, which is derived from D-(+)-lactic acid, C6 unit 3, and
Wittig reagent 4 (Scheme 1), followed by cyclization to form
the lactam.
a
Readily available aldehyde (+)-56 ([R]22 +14.4° (c 0.50,
Reagents and conditions: (a) (i) ZnCl2, (ii) LiCH(CO2-t-Bu)2, THF,
D
-78 °C (53%); (b) CF3CO2H, CH2Cl2, 0 °C (80%); (c) Me3SiCl, imidazole,
DMF, 0 °C (94%); (d) (i) LHMDS, (ii) I2, -78 °C; (e) TBAF, THF, -45
to -15 °C (52% two steps); (f) HCO2H, rt; (g) Me(MeO)NH‚HCl, PyBOP,
i-Pr2NEt, CH2Cl2, 0 °C (69% from 8); (h) NH3, MeOH, rt; (i) TBDMSCl,
imidazole, DMF, 0 °C to rt (93% from 10); (j) (Z)-Br(CH3)CdCH-
(CH2)3OH, t-BuLi, THF, -78 °C (83%); (k) Dess-Martin reagent,
CH2Cl2, rt (81%).
CHCl3)) derived from D-(+)-lactic acid was subjected to
stereoselective aldol reaction with malonate anion to intro-
† With regard to this investigation, a patent application was filed before
J apanese Patent Office on Oct 30, 1997, as patent filing no. H9-297983.
(1) (a) Barde, Y, A.; Neuron 1989, 2, 1525-1535. (b) Ross, R. A.; Biedeler,
J . L. Cancer Res. 1985, 45, 1628-1632.
(2) Hefti, F. J . Neurobiol. 1994, 25, 1418-1435.
(3) Kakeya, H.; Takahashi, I.; Okada, G.; Isono, K.; Osada, H. J . Antibiot.
1995, 48, 733-735.
duce a chiral center at the C-13 position of epolactaene
(Scheme 2). The diastereoselective aldol reaction7 was
achieved by treating the aldehyde 5 with lithium malonate
(4) Kakeya, H.; Onozawa, C.; Sato, M.; Arai, K.; Osada, H. J . Med. Chem.
1997, 40, 391-394.
8
(5) Lactacystin has also been reported as the same neurite outgrowth
activity. Isolation: (a) Omura, S.; Fujimoto, T.; Otoguro, K.; Matsuzaki,
K.; Moriguchi, R.; Tanaka, H.; Sasaki, Y. J . Antibiot. 1991, 44, 113-116.
(b) Omura, S.; Matsuzaki, K.; Fujimoto, T.; Kosuge, K.; Furuya, T.; Fujita,
S.; Nakagawa, A. J . Antibiot. 1991, 44, 117-118. Synthesis: (c) Corey, E.
J .; Reichard, G. A. J . Am. Chem. Soc. 1992, 114, 10677-10678. (d) Corey,
E. J .; Reichard, G. A., Kania, R. Tetrahedron Lett. 1993, 34, 6977-6980.
(e) Sunazuka, T.; Nagamitsu, T.; Matsuzaki, K.; Tanaka, H.; Omura, S.;
Smith, A. B., III. J . Am. Chem. Soc. 1993, 115, 5302. (f) Uno, H.; Baldwin,
J . E.; Russell, A. T. J . Am. Chem. Soc. 1994, 116, 2139-2140. (g) Chida,
N.; Takeoka, J .; Tsutsumi, N.; Ogawa, S. J . Chem. Soc., Chem. Commun.
1995, 793-794.
in the presence of ZnCl2 at -78 °C to give the desired syn
product 6 as 9:1 diastereomeric mixture in 53% yield9 (85%
yield based on 62% conversion of the aldehyde 5 by 1H NMR
analysis). After deprotection (80%) and silylation (94%) of
6, the resulting bissilyl ether was purified by silica gel flash
column chromatography to remove the minor anti isomer
and then iodinated to obtain the R-iodo compound 7.
Subsequent desilylation with tetrabutylammonium fluoride
(TBAF) gave the epoxide 8 in 52% yield (two steps). Treat-
ment of this compound with formic acid provided epoxy
lactone 9, diastereoselectively generating a chiral center at
the C-13 position. The lactone 9 was converted to the
Weinreb amide10 10 by treating with (1H-benzotriazol-1-
(6) Aldehyde (-)-5 ([R]24D -14.4° (c 1.14, CHCl3)) was synthesized by Mori
et al.: Mori, K.; Kikuchi, H. Liebigs. Ann. Chem. 1989, 963-967.
(7) For a review of stereoselective aldol reactions, see: (a) Franklin, A.
S.; Paterson, I. Contemp. Org. Synth. 1994, 1, 317-338. (b) Heathcock, C.
H. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.;
Pergamon: Oxford, 1991; Vol. 2, pp 181-238. (c) Heathcock, C. H. In
Asymmetric Synthesis; Morrison, J . D., Eds.; Academic Press: New York,
1984; Vol. 3, pp 111-212. (d) Evans, D. A.; Nelson, J . V.; Taber, T. R. In
Topics in Stereochemistry; Allinger, N. L., Eliel, E. L., Wilen, S. H., Eds.;
J ohn Wiley & Sons: New York, 1982; Vol. 13, pp 1-115.
(8) No aldol product was obtained in the absence of ZnCl2.
(9) The detailed study on this reaction will be described elsewhere.
(10) Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815-3818.
S0022-3263(98)00087-5 CCC: $15.00 © 1998 American Chemical Society
Published on Web 03/11/1998